Latest News
Helix BioPharma Corp.
- Helix BioPharma Corp. (TSX:HBP): What Could Move the Stock After the Latest Market Developments?
- Why Helix BioPharma Corp. (TSX:HBP) Is on Investors’ Radar: Clinical-Development Milestones And Funding Runway and What Comes Next
- Helix BioPharma Corp. (TSXV:HBP): Why Investors Are Watching This Healthcare Stock on 27 October 2026
- Helix BioPharma Corp. (TSX:HBP) Advances as Renewed Buying Interest Lifts Investor Sentiment
- Helix BioPharma Corp. Plunges as Clinical Stage Oncology Developers Confront Funding Scrutiny
- Helix BioPharma Corp. Estimates – TSX:HBP
- Helix BioPharma (TSX:HBP) Gears Up for Year-End Results as New CMO Signals Next Clinical Push for This TSX Oncology Stock
- Early Warning Press Release Regarding The Disposition Of Common Shares Of Helix Biopharma Corp. By Jerzy Wilczewski
- Helix BioPharma Corp. (TSX:HBP) in Focus: What Could Move the Stock Next?
- Off-market insider selling at Helix BioPharma (HBP)
- Helix BioPharma Stock Slides 6.12% as Funding Pressure and Biotech Uncertainty Raise Downside Risk
- Helix BioPharma Stock Slides 7.02% — Funding Risk and Clinical Uncertainty Raise Downside Concerns
Headlines from the last 30 days, linking to the original publishers. See all market news →